tiprankstipranks
Zymergen (ZY)
NASDAQ:ZY
Holding ZY?
Track your performance easily

Zymergen (ZY) Income Statement

0 Followers

Zymergen Income Statement

Last quarter (Q ), Zymergen's total revenue was $2.42M, a decrease of -58.94% from the same quarter last year. In Q, Zymergen's net income was $-116.47M. See Zymergen’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 21Dec 20Dec 19
Total Revenue
$ 14.09M$ 16.74M$ 13.28M$ 15.42M
Cost of Revenue
$ 48.95M$ 69.72M$ 84.82M$ 102.64M
Gross Profit
$ -34.86M$ -52.98M$ -71.53M$ -87.22M
Operating Expense
$ 232.31M$ 265.78M$ 169.56M$ 136.10M
Operating Income
$ -267.17M$ -318.75M$ -241.09M$ -223.32M
Net Non Operating Interest Income Expense
$ -26.57M$ -14.64M$ -10.47M$ 1.98M
Other Income Expense
$ -71.17M$ -28.34M$ -10.69M$ -15.45M
Pretax Income
$ -364.91M$ -361.73M$ -262.24M$ -236.79M
Tax Provision
$ 44.00K$ 51.00K$ -49.00K$ 8.00K
Earnings From Equity Interest Net Of Tax
----
Net Income Common Stockholders
$ -364.95M$ -361.79M$ -262.19M$ -236.80M
Basic EPS
$ -3.55$ -4.87$ -2.68$ -2.42
Diluted EPS
$ -3.55$ -4.89$ -2.68$ -2.42
Basic Average Shares
$ 411.40M$ 74.23M$ 97.94M$ 97.94M
Diluted Average Shares
$ 411.72M$ 74.31M$ 97.94M$ 97.94M
Dividend Per Share
----
Total Operating Income As Reported
----
Reported Normalized Basic E P S
----
Reported Normalized Diluted E P S
----
Rent Expense Supplemental
----
Total Expenses
$ 281.26M$ 335.50M$ 254.37M$ 238.74M
Net Income From Continuing And Discontinued Operation
$ -364.95M$ -361.79M$ -262.19M$ -236.80M
Normalized Income
$ -314.06M$ -342.10M$ -251.97M$ -225.41M
Interest Expense
$ 26.63M$ 14.71M$ 10.96M$ 2.94M
EBIT
$ -338.27M$ -347.03M$ -251.28M$ -233.85M
EBITDA
$ -316.70M$ -326.33M$ -232.58M$ -218.65M
Currency in USD

Zymergen Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis